<DOC>
	<DOCNO>NCT00560417</DOCNO>
	<brief_summary>This study compare insulin lispro protamine suspension ( ILPS ) insulin glargine combination patient 's oral diabetes medication exenatide , ability control blood sugar patient type 2 diabetes .</brief_summary>
	<brief_title>Comparison Two Basal Insulins Patients With Type 2 Diabetes Taking Oral Diabetes Medicines Exenatide</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Must type 2 diabetes Must least 18 year age less 75 year age Must take exenatide 10 microgram twice day ( BID ) least 3 month Must take one follow oral diabetes medication regimens least 3 month : ( 1 ) metformin ( 2 ) metformin + sulfonylurea ( 3 ) metformin + thiazolidinedione ( TZD ) . Doses must follow : Metformin1500 mg/day , Sulfonylurea1/2 maximum daily dose accord product label , TZD30 mg/day pioglitazone Must hemoglobin A1C great equal 7.0 % less equal 10.0 % Must use insulin regular basis past 2 year Must take glucoselowering medication include inclusion criterion past 3 month Must one episode severe hypoglycemia past 6 month Must clinically significant hematologic , oncologic , renal , cardiac , hepatic , gastrointestinal disease Must pregnant intend get pregnant course study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>